SANGIOLO, Dario
SANGIOLO, Dario
ONCOLOGIA
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies
2017-01-01 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives.
2013-01-01 Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma.
2014-01-01 Sangiolo D;Mesiano G;Gammaitoni L;Aglietta M;Grignani G
Adoptive immunotherapy against ovarian cancer
2016-01-01 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Adoptive immunotherapy against sarcomas.
2015-01-01 Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D.
Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD
2006-01-01 CARNEVALE-SCHIANCA F; CIGNETTI A; CAPALDI A; VITAGGIO K; VALLARIO A; RICCHIARDI A; SPERTI E; FERRARIS R; GATTI M; GRIGNANI G; ROTA-SCALABRINI D; GEUNA M; FIZZOTTI M; SANGIOLO D; SOTTILE A; DE ROSA G; BUCCI AR; LAMBERTENGHI-DELILIERS G; BENEDETTI E; NASH R; AGLIETTA M
Alloreactivity and antitumor activity segregate within two distinct subsets of Cytokine-Induced Killer Cells: Implications for their infusion Across major HLA-barriers.
2008-01-01 Sangiolo; Martinuzzi; Todorovic; Vitaggio; Vallario; Jordaney; Carnevale-Schianca;Capaldi; Geuna; Casorzo; Nash; Aglietta; Cignetti
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells
2017-01-01 Mesiano, Giulia; Zini, Roberta; Montagner, Giulia; Bianchi, Nicoletta; Manfredini, Rossella; Chillemi, Antonella; Aglietta, Massimo; Grignani, Giovanni; Lampronti, Ilaria; Fiorino, Erika; Malavasi, Fabio; Sangiolo, Dario; Gambari, Roberto; Ferrari, Davide
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19
2022-01-01 Vitali, Letizia; Merlini, Alessandra; Galvagno, Federica; Proment, Alessia; Sangiolo, Dario
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody
2018-01-01 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Leuci, Valeria; Rotolo, Ramona; Donini, Chiara; Basiricò, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Sibilia, Maria; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy
2019-01-01 Rotolo, Ramona; Leuci, Valeria; Donini, Chiara; Cykowska, Anna; Gammaitoni, Loretta; Medico, Giovanni; Valabrega, Giorgio; Aglietta, Massimo; Sangiolo, Dario
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
2018-01-01 Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D.
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective
2021-01-01 Donini C.; Rotolo R.; Proment A.; Aglietta M.; Sangiolo D.; Leuci V.
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer
2022-01-01 Mariniello, Annapaola; Tabbò, Fabrizio; Indellicati, Davide; Tesauro, Martina; Rezmives, Nicole Alessia; Reale, Maria Lucia; Listì, Angela; Capelletto, Enrica; Carnio, Simona; Bertaglia, Valentina; Mecca, Caterina; Consito, Lorena; De Filippis, Marco; Bungaro, Maristella; Paratore, Chiara; Di Maio, Massimo; Passiglia, Francesco; Righi, Luisella; Sangiolo, Dario; Novello, Silvia; Geuna, Massimo; Bironzo, Paolo
Comparison of post-transplant events and outcomes in patients affected by haematological or solid malignancies undergone to a non-myeloablative allogeneic haematopoietic stem cell transplantation in progressive disease
2010-01-01 Caravelli D; Carnevale-Schianca F; Bruno B; Coha V; Sorasio R; Grignani G; Rota-Scalabrini D; Fizzotti M; Gatti M; Giaccone L; Capaldi A; Cignetti A; Sangiolo D; Boccadoro M; Aglietta M
Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity?
2011-01-01 Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G.
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
2023-01-01 Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes
2020-01-01 Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy
2018-01-01 Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies | 2017 | Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario | |
| Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
| Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. | 2013 | Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G | |
| Activity of cytokine-induced killer cells against bone and soft tissue sarcoma. | 2014 | Sangiolo D;Mesiano G;Gammaitoni L;Aglietta M;Grignani G | |
| Adoptive immunotherapy against ovarian cancer | 2016 | Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio | |
| Adoptive immunotherapy against sarcomas. | 2015 | Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D. | |
| Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD | 2006 | CARNEVALE-SCHIANCA F; CIGNETTI A; CAPALDI A; VITAGGIO K; VALLARIO A; RICCHIARDI A; SPERTI E; FERRARIS R; GATTI M; GRIGNANI G; ROTA-SCALABRINI D; GEUNA M; FIZZOTTI M; SANGIOLO D; SOTTILE A; DE ROSA G; BUCCI AR; LAMBERTENGHI-DELILIERS G; BENEDETTI E; NASH R; AGLIETTA M | |
| Alloreactivity and antitumor activity segregate within two distinct subsets of Cytokine-Induced Killer Cells: Implications for their infusion Across major HLA-barriers. | 2008 | Sangiolo; Martinuzzi; Todorovic; Vitaggio; Vallario; Jordaney; Carnevale-Schianca;Capaldi; Geuna; Casorzo; Nash; Aglietta; Cignetti | |
| Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells | 2017 | Mesiano, Giulia; Zini, Roberta; Montagner, Giulia; Bianchi, Nicoletta; Manfredini, Rossella; Chillemi, Antonella; Aglietta, Massimo; Grignani, Giovanni; Lampronti, Ilaria; Fiorino, Erika; Malavasi, Fabio; Sangiolo, Dario; Gambari, Roberto; Ferrari, Davide | |
| Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19 | 2022 | Vitali, Letizia; Merlini, Alessandra; Galvagno, Federica; Proment, Alessia; Sangiolo, Dario | |
| BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody | 2018 | Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Leuci, Valeria; Rotolo, Ramona; Donini, Chiara; Basiricò, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Sibilia, Maria; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario | |
| CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy | 2019 | Rotolo, Ramona; Leuci, Valeria; Donini, Chiara; Cykowska, Anna; Gammaitoni, Loretta; Medico, Giovanni; Valabrega, Giorgio; Aglietta, Massimo; Sangiolo, Dario | |
| CD44v6 as innovative sarcoma target for CAR-redirected CIK cells | 2018 | Leuci, V.; Casucci, G.M.; Grignani, G.; Rotolo, R.; Rossotti, U.; Vigna, E.; Gammaitoni, L.; Mesiano, G.; Fiorino, E.; Donini, C.; Pisacane, A.; ambrosio, L.D.; Pignochino, Y.; Aglietta, M.; Bondanza, A.; Sangiolo, D. | |
| Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective | 2021 | Donini C.; Rotolo R.; Proment A.; Aglietta M.; Sangiolo D.; Leuci V. | |
| Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer | 2022 | Mariniello, Annapaola; Tabbò, Fabrizio; Indellicati, Davide; Tesauro, Martina; Rezmives, Nicole Alessia; Reale, Maria Lucia; Listì, Angela; Capelletto, Enrica; Carnio, Simona; Bertaglia, Valentina; Mecca, Caterina; Consito, Lorena; De Filippis, Marco; Bungaro, Maristella; Paratore, Chiara; Di Maio, Massimo; Passiglia, Francesco; Righi, Luisella; Sangiolo, Dario; Novello, Silvia; Geuna, Massimo; Bironzo, Paolo | |
| Comparison of post-transplant events and outcomes in patients affected by haematological or solid malignancies undergone to a non-myeloablative allogeneic haematopoietic stem cell transplantation in progressive disease | 2010 | Caravelli D; Carnevale-Schianca F; Bruno B; Coha V; Sorasio R; Grignani G; Rota-Scalabrini D; Fizzotti M; Gatti M; Giaccone L; Capaldi A; Cignetti A; Sangiolo D; Boccadoro M; Aglietta M | |
| Complete Resolution of Life-Threatening Bleomycin-Induced Pneumonitis After Treatment With Imatinib Mesylate in a Patient With Hodgkin's Lymphoma: Hope for Severe Chemotherapy-Induced Toxicity? | 2011 | Carnevale-Schianca F; Gallo S; Rota-Scalabrini D; Sangiolo D; Fizzotti M; Caravelli D; Capaldi A; Anselmetti G; Palesandro E; D'Ambrosio L; Coha V; Obert R; Aglietta M; Grignani G. | |
| CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma | 2023 | Giraudo, Lidia; Cattaneo, Giulia; Gammaitoni, Loretta; Iaia, Ilenia; Donini, Chiara; Massa, Annamaria; Centomo, Maria Laura; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Picciotto, Franco; Berrino, Enrico; Marchiò, Caterina; Merlini, Alessandra; Paruzzo, Luca; Poletto, Stefano; Caravelli, Daniela; Biolato, Andrea Michela; Bortolot, Valentina; Landoni, Elisa; Ventin, Marco; Ferrone, Cristina R; Aglietta, Massimo; Dotti, Gianpietro; Leuci, Valeria; Carnevale-Schianca, Fabrizio; Sangiolo, Dario | |
| CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes | 2020 | Leuci, Valeria; Donini, Chiara; Grignani, Giovanni; Rotolo, Ramona; Mesiano, Giulia; Fiorino, Erika; Gammaitoni, Loretta; D'Ambrosio, Lorenzo; Merlini, Alessandra; Landoni, Elisa; Medico, Enzo; Capellero, Sonia; Giraudo, Lidia; Cattaneo, Giulia; Iaia, Ilenia; Pignochino, Ymera; Basiricò, Marco; Vigna, Elisa; Pisacane, Alberto; Fagioli, Franca; Ferrone, Soldano; Aglietta, Massimo; Gianpietro, Dotti; Sangiolo, Dario | |
| Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy | 2018 | Mesiano, Giulia; Grignani, Giovanni; Fiorino, Erika; Leuci, Valeria; Rotolo, Ramona; D'Ambrosio, Lorenzo; Salfi, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Pisacane, Alberto; Butera, Sara; Pignochino, Ymera; Basiricó, Marco; Capozzi, Federica; Sapino, Anna; Aglietta, Massimo; Sangiolo, Dario |